Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
La Revue De Medecine Interne
|
October 9, 2004
[Bilateral optic neuropathy revealing systemic sarcoidosis]
P Guilpain, M A Andreu, N Cassoux, et al.
AIDS (London, England)
|
February 24, 2001
Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy
M Jouan, M Savès, R Tubiana, et al.
Journal Francais D'Ophtalmologie
|
May 16, 2015
Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009)
L Lumbroso-Le Rouic, A Savignoni, C Levy-Gabriel, et al.
Journal Francais D'Ophtalmologie
|
January 28, 2017
Evisceration and ocular tumors: What are the consequences?
S Lemaître, A Lecler, C Lévy-Gabriel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2019
Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective 'proof of concept' phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)†
H Ghesquieres, M Chevrier, M Laadhari, et al.
Bone Marrow Transplantation
|
April 25, 2017
High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study
E Schorb, C P Fox, K Fritsch, et al.
Journal Francais D'Ophtalmologie
|
May 16, 2020
[Categorization of the degree of urgency according to ophthalmology procedures or situations]
C Arndt, F Audrun, B Bodaghi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 7, 2019
Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network
C Soussain, S Choquet, M Blonski, et al.
ESMO Open
|
April 22, 2026
Uveal melanoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
S Piperno-Neumann, M Angi, P A Ascierto, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
La Revue De Medecine Interne
|
October 9, 2004
[Bilateral optic neuropathy revealing systemic sarcoidosis]
P Guilpain, M A Andreu, N Cassoux, et al.
AIDS (London, England)
|
February 24, 2001
Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy
M Jouan, M Savès, R Tubiana, et al.
Journal Francais D'Ophtalmologie
|
May 16, 2015
Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009)
L Lumbroso-Le Rouic, A Savignoni, C Levy-Gabriel, et al.
Journal Francais D'Ophtalmologie
|
January 28, 2017
Evisceration and ocular tumors: What are the consequences?
S Lemaître, A Lecler, C Lévy-Gabriel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2019
Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective 'proof of concept' phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)†
H Ghesquieres, M Chevrier, M Laadhari, et al.
Bone Marrow Transplantation
|
April 25, 2017
High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study
E Schorb, C P Fox, K Fritsch, et al.
Journal Francais D'Ophtalmologie
|
May 16, 2020
[Categorization of the degree of urgency according to ophthalmology procedures or situations]
C Arndt, F Audrun, B Bodaghi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 7, 2019
Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network
C Soussain, S Choquet, M Blonski, et al.
ESMO Open
|
April 22, 2026
Uveal melanoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
S Piperno-Neumann, M Angi, P A Ascierto, et al.
Page
of 8